Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.
2.

Suppression of CCR5-tropic HIV type 1 infection by OX40 stimulation via enhanced production of β-chemokines.

Tanaka R, Takahashi Y, Kodama A, Saito M, Ansari AA, Tanaka Y.

AIDS Res Hum Retroviruses. 2010 Oct;26(10):1147-54. doi: 10.1089/aid.2010.0043. Epub 2010 Sep 21.

PMID:
20854204
3.

Requirements for the functional expression of OX40 ligand on human activated CD4+ and CD8+ T cells.

Kondo K, Okuma K, Tanaka R, Zhang LF, Kodama A, Takahashi Y, Yamamoto N, Ansari AA, Tanaka Y.

Hum Immunol. 2007 Jul;68(7):563-71. Epub 2007 Apr 13.

PMID:
17584577
4.

Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses.

Adachi T, Tanaka R, Kodama A, Saito M, Takahashi Y, Ansari AA, Tanaka Y.

Retrovirology. 2011 Oct 22;8:84. doi: 10.1186/1742-4690-8-84.

5.

OX40 stimulation by gp34/OX40 ligand enhances productive human immunodeficiency virus type 1 infection.

Takahashi Y, Tanaka Y, Yamashita A, Koyanagi Y, Nakamura M, Yamamoto N.

J Virol. 2001 Aug;75(15):6748-57.

6.

Identification of rat OX40 ligand by molecular cloning.

Akiba H, Atsuta M, Yagita H, Okumura K.

Biochem Biophys Res Commun. 1998 Oct 9;251(1):131-6.

PMID:
9790919
7.

Induction of OX40, a receptor of gp34, on T cells by trans-acting transcriptional activator, Tax, of human T-cell leukemia virus type I.

Higashimura N, Takasawa N, Tanaka Y, Nakamura M, Sugamura K.

Jpn J Cancer Res. 1996 Mar;87(3):227-31.

PMID:
8613423
9.

Enhancement of OX40-induced apoptosis by TNF coactivation in OX40-expressing T cell lines in vitro leading to decreased targets for HIV type 1 production.

Takahashi Y, Tanaka R, Yamamoto N, Tanaka Y.

AIDS Res Hum Retroviruses. 2008 Mar;24(3):423-35. doi: 10.1089/aid.2007.0092.

PMID:
18327975
10.

The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells.

Imura A, Hori T, Imada K, Ishikawa T, Tanaka Y, Maeda M, Imamura S, Uchiyama T.

J Exp Med. 1996 May 1;183(5):2185-95.

11.

Characterization of rat OX40 ligand by monoclonal antibody.

Satake Y, Akiba H, Takeda K, Atsuta M, Yagita H, Okumura K.

Biochem Biophys Res Commun. 2000 Apr 21;270(3):1041-8.

PMID:
10772947
12.

A recombinant vesicular stomatitis virus encoding HIV-1 receptors and human OX40 ligand efficiently eliminates HIV-1-infected CD4-positive T cells expressing OX40.

Tsuruno C, Okuma K, Takahashi Y, Tanaka R, Tanaka Y, Takahama Y, Hamaguchi Y, Hamaguchi I, Yamaguchi K.

Hum Immunol. 2011 Apr;72(4):295-304. doi: 10.1016/j.humimm.2011.01.007. Epub 2011 Jan 21.

PMID:
21262309
13.

Functional CD4 T cells after intercellular molecular transfer of 0X40 ligand.

Baba E, Takahashi Y, Lichtenfeld J, Tanaka R, Yoshida A, Sugamura K, Yamamoto N, Tanaka Y.

J Immunol. 2001 Jul 15;167(2):875-83.

14.

Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response.

Ukyo N, Hori T, Yanagita S, Ishikawa T, Uchiyama T.

Immunology. 2003 Jun;109(2):226-31.

15.

OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.

Shibahara I, Saito R, Zhang R, Chonan M, Shoji T, Kanamori M, Sonoda Y, Kumabe T, Kanehira M, Kikuchi T, So T, Watanabe T, Takahashi H, Iwabuchi E, Tanaka Y, Shibahara Y, Sasano H, Ishii N, Tominaga T.

Mol Cancer. 2015 Feb 15;14:41. doi: 10.1186/s12943-015-0307-3.

16.

Evidence for a post-entry barrier to R5 HIV-1 infection of CD4 memory T cells.

Vyakarnam A, Eyeson J, Teo I, Zuckerman M, Babaahmady K, Schuitemaker H, Shaunak S, Rostron T, Rowland-Jones S, Simmons G, Clapham P.

AIDS. 2001 Sep 7;15(13):1613-26.

PMID:
11546935
17.

Characterization of a chemokine receptor CCR5-negative T cell line and its use in determining human immunodeficiency virus type 1 phenotype.

Binninger-Schinzel D, Müller D, Wolf T, Krause B, Meye B, Winskowsky G, Raupp S, Norley S, Brodt R, Werner A.

J Med Virol. 2008 Feb;80(2):192-200.

PMID:
18098144
18.

Rapid induction of OX40 ligand on primary T cells activated under DNA-damaging conditions.

Kondo K, Okuma K, Tanaka R, Matsuzaki G, Ansari AA, Tanaka Y.

Hum Immunol. 2008 Sep;69(9):533-42. doi: 10.1016/j.humimm.2008.07.001. Epub 2008 Aug 15.

PMID:
18718855
19.
20.

Limited expression of R5-tropic HIV-1 in CCR5-positive type 1-polarized T cells explained by their ability to produce RANTES, MIP-1alpha, and MIP-1beta.

Annunziato F, Galli G, Nappi F, Cosmi L, Manetti R, Maggi E, Ensoli B, Romagnani S.

Blood. 2000 Feb 15;95(4):1167-74.

Items per page

Supplemental Content

Write to the Help Desk